Relmada Therapeutics Inc.

NASDAQ: RLMD · Real-Time Price · USD
0.63
0.02 (3.75%)
At close: Aug 15, 2025, 3:59 PM
0.65
1.88%
After-hours: Aug 15, 2025, 07:40 PM EDT

Relmada Therapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Net Income
-79.98M -98.79M -157.04M -125.75M
Depreciation & Amortization
n/a n/a n/a 1.26K
Stock-Based Compensation
30.19M 43.81M 44.19M 40.49M
Other Working Capital
-2.21M 4.32M 10.6M -10.71M
Other Non-Cash Items
-381.66K 241.31K -1.55M 1.25M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-1.58M 3.08M 10.59M -7.86M
Operating Cash Flow
-51.76M -51.66M -103.8M -91.87M
Capital Expenditures
n/a -4 -3 -5
Cash Acquisitions
n/a n/a n/a n/a
Purchase of Investments
-12.08M -90.46M -47.29M -222.98M
Sales Maturities Of Investments
63.64M 140.92M 67.03M 168.86M
Other Investing Acitivies
n/a n/a n/a n/a
Investing Cash Flow
51.56M 50.45M 19.73M -54.12M
Debt Repayment
n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a
Other Financial Acitivies
-287.09K -98.46K 2.29M 2.63M
Financial Cash Flow
-40.34K -98.46K 45.02M 187.94M
Net Cash Flow
-234.54K -1.3M -39.05M 41.95M
Free Cash Flow
-51.76M -51.66M -103.8M -91.87M